These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 8613381

  • 21. Passive therapy with humanized anti-staphylococcal enterotoxin B antibodies attenuates systemic inflammatory response and protects from lethal pneumonia caused by staphylococcal enterotoxin B-producing Staphylococcus aureus.
    Karau MJ, Tilahun ME, Krogman A, Osborne BA, Goldsby RA, David CS, Mandrekar JN, Patel R, Rajagopalan G.
    Virulence; 2017 Oct 03; 8(7):1148-1159. PubMed ID: 27925510
    [Abstract] [Full Text] [Related]

  • 22. Biodegradable microspheres as a vaccine delivery system.
    Eldridge JH, Staas JK, Meulbroek JA, McGhee JR, Tice TR, Gilley RM.
    Mol Immunol; 1991 Mar 03; 28(3):287-94. PubMed ID: 2017198
    [Abstract] [Full Text] [Related]

  • 23. Systemic and mucosal immune responses of mice to aluminium-adsorbed or aluminium-non-adsorbed tetanus toxoid administered intranasally with recombinant cholera toxin B subunit.
    Isaka M, Yasuda Y, Kozuka S, Miura Y, Taniguchi T, Matano K, Goto N, Tochikubo K.
    Vaccine; 1998 Oct 03; 16(17):1620-6. PubMed ID: 9713937
    [Abstract] [Full Text] [Related]

  • 24. HIV-1 neutralizing antibodies in the genital and respiratory tracts of mice intranasally immunized with oligomeric gp160.
    VanCott TC, Kaminski RW, Mascola JR, Kalyanaraman VS, Wassef NM, Alving CR, Ulrich JT, Lowell GH, Birx DL.
    J Immunol; 1998 Feb 15; 160(4):2000-12. PubMed ID: 9469464
    [Abstract] [Full Text] [Related]

  • 25. Mucosal immunization with a flagellin-adjuvanted Hgp44 vaccine enhances protective immune responses in a murine Porphyromonas gingivalis infection model.
    Puth S, Hong SH, Park MJ, Lee HH, Lee YS, Jeong K, Kang IC, Koh JT, Moon B, Park SC, Rhee JH, Lee SE.
    Hum Vaccin Immunother; 2017 Dec 02; 13(12):2794-2803. PubMed ID: 28604268
    [Abstract] [Full Text] [Related]

  • 26. Isotype switching increases efficacy of antibody protection against staphylococcal enterotoxin B-induced lethal shock and Staphylococcus aureus sepsis in mice.
    Varshney AK, Wang X, Aguilar JL, Scharff MD, Fries BC.
    mBio; 2014 Jun 10; 5(3):e01007-14. PubMed ID: 24917594
    [Abstract] [Full Text] [Related]

  • 27. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
    de Haan A, Haijema BJ, Voorn P, Meijerhof T, van Roosmalen ML, Leenhouts K.
    Vaccine; 2012 Jul 06; 30(32):4884-91. PubMed ID: 22537989
    [Abstract] [Full Text] [Related]

  • 28. Protection against bacterial superantigen staphylococcal enterotoxin B by passive vaccination.
    LeClaire RD, Hunt RE, Bavari S.
    Infect Immun; 2002 May 06; 70(5):2278-81. PubMed ID: 11953360
    [Abstract] [Full Text] [Related]

  • 29. Intranasal and sublingual delivery of inactivated polio vaccine.
    Kraan H, Soema P, Amorij JP, Kersten G.
    Vaccine; 2017 May 09; 35(20):2647-2653. PubMed ID: 28400164
    [Abstract] [Full Text] [Related]

  • 30. Monoclonal antibodies protect from Staphylococcal Enterotoxin K (SEK) induced toxic shock and sepsis by USA300 Staphylococcus aureus.
    Aguilar JL, Varshney AK, Pechuan X, Dutta K, Nosanchuk JD, Fries BC.
    Virulence; 2017 Aug 18; 8(6):741-750. PubMed ID: 27715466
    [Abstract] [Full Text] [Related]

  • 31. Intranasal immunization of mice with influenza vaccine in combination with the adjuvant LT-R72 induces potent mucosal and serum immunity which is stronger than that with traditional intramuscular immunization.
    Barackman JD, Ott G, O'Hagan DT.
    Infect Immun; 1999 Aug 18; 67(8):4276-9. PubMed ID: 10417205
    [Abstract] [Full Text] [Related]

  • 32. Intranasal Protollin/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infection.
    Jones T, Adamovicz JJ, Cyr SL, Bolt CR, Bellerose N, Pitt LM, Lowell GH, Burt DS.
    Vaccine; 2006 Mar 06; 24(10):1625-32. PubMed ID: 16243411
    [Abstract] [Full Text] [Related]

  • 33. Repeated intranasal instillation with staphylococcal enterotoxin B induces nasal allergic inflammation in guinea pigs.
    Tang X, Sun R, Hong S, Hu G, Yang Y.
    Am J Rhinol Allergy; 2011 Mar 06; 25(3):176-81. PubMed ID: 21679529
    [Abstract] [Full Text] [Related]

  • 34. c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infection.
    Hu DL, Narita K, Hyodo M, Hayakawa Y, Nakane A, Karaolis DK.
    Vaccine; 2009 Jul 30; 27(35):4867-73. PubMed ID: 19406185
    [Abstract] [Full Text] [Related]

  • 35. Safety and Immunogenicity of a Parenterally Administered, Structure-Based Rationally Modified Recombinant Staphylococcal Enterotoxin B Protein Vaccine, STEBVax.
    Chen WH, Pasetti MF, Adhikari RP, Baughman H, Douglas R, El-Khorazaty J, Greenberg N, Holtsberg FW, Liao GC, Reymann MK, Wang X, Warfield KL, Aman MJ.
    Clin Vaccine Immunol; 2016 Dec 30; 23(12):918-925. PubMed ID: 27707765
    [Abstract] [Full Text] [Related]

  • 36. Humoral immunity to aerosolized staphylococcal enterotoxin B (SEB), a superantigen, in monkeys vaccinated with SEB toxoid-containing microspheres.
    Tseng J, Komisar JL, Trout RN, Hunt RE, Chen JY, Johnson AJ, Pitt L, Ruble DL.
    Infect Immun; 1995 Aug 30; 63(8):2880-5. PubMed ID: 7542634
    [Abstract] [Full Text] [Related]

  • 37. Murine host responses to respiratory syncytial virus (RSV) following intranasal administration of a Protollin-adjuvanted, epitope-enhanced recombinant G protein vaccine.
    Huang Y, Cyr SL, Burt DS, Anderson R.
    J Clin Virol; 2009 Apr 30; 44(4):287-91. PubMed ID: 19233722
    [Abstract] [Full Text] [Related]

  • 38. Generation of protective immunity by inactivated recombinant staphylococcal enterotoxin B vaccine in nonhuman primates and identification of correlates of immunity.
    Boles JW, Pitt ML, LeClaire RD, Gibbs PH, Torres E, Dyas B, Ulrich RG, Bavari S.
    Clin Immunol; 2003 Jul 30; 108(1):51-9. PubMed ID: 12865071
    [Abstract] [Full Text] [Related]

  • 39. A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM(197)) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery.
    McNeela EA, O'Connor D, Jabbal-Gill I, Illum L, Davis SS, Pizza M, Peppoloni S, Rappuoli R, Mills KH.
    Vaccine; 2000 Dec 08; 19(9-10):1188-98. PubMed ID: 11137256
    [Abstract] [Full Text] [Related]

  • 40. The concomitant use of the LTK63 mucosal adjuvant and of chitosan-based delivery system enhances the immunogenicity and efficacy of intranasally administered vaccines.
    Baudner BC, Giuliani MM, Verhoef JC, Rappuoli R, Junginger HE, Giudice GD.
    Vaccine; 2003 Sep 08; 21(25-26):3837-44. PubMed ID: 12922117
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.